Form 4: National Healthcare Corp. Senior VP Exercises Stock Options, Adjusts Holdings
Insider Transaction Report
Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), reported the exercise of stock options and subsequent adjustment of his common stock holdings on June 6, 2025.
Summary
- Josh A. McCreary, Senior VP & General Counsel of National Healthcare Corp. (NHC), executed transactions on June 6, 2025, involving the company's common stock and stock options.
- He exercised 3,734 options to purchase common stock at an exercise price of $63.96 per share.
- Following the exercise, 2,805 shares of common stock were disposed of by the company at a price of $106.1 per share to cover the exercise price and withholding tax obligations.
- After these transactions, Mr. McCreary beneficially owns 8,453 shares of common stock directly.
- He also holds remaining options to purchase common stock: 8,000 options at $53.94 (exercisable 03/08/2024, expires 03/08/2028), 12,000 options at $94.1 (exercisable 03/05/2025, expires 03/05/2029), and 13,500 options at $90.62 (exercisable 02/24/2026, expires 02/24/2030).
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While shares were disposed of, it was for a routine purpose (tax/exercise cost), and the underlying action was the exercise of options, indicating the executive found value in exercising them.
Positives
- The exercise of stock options by a Senior VP indicates a perceived value in the company's stock at the exercise price.
- The transactions are part of a routine executive compensation plan, specifically the 2020 Omnibus Equity Incentive Plan, suggesting structured and transparent compensation practices.
Negatives
- A portion of the acquired shares (2,805 shares) was immediately disposed of to cover the exercise price and tax obligations, which reduces the direct beneficial ownership of the executive post-exercise.
Future Outlook
This Form 4 filing does not provide forward-looking statements or guidance regarding the company's future performance or strategic outlook. It solely reports on an insider's stock transactions.
Industry Context
This filing is a routine disclosure of an insider stock transaction within the healthcare industry. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The transaction represents a routine executive compensation event and does not indicate a significant change in the company's operational or financial strategy. The slight reduction in direct beneficial ownership due to tax withholding is standard.
Key Dates
| Date | Description |
|---|---|
| 02/18/2022 | Date stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan. |
| 02/18/2023 | Date 3,734 stock options became exercisable. |
| 03/08/2024 | Date 8,000 stock options became exercisable. |
| 03/05/2025 | Date 12,000 stock options became exercisable. |
| 06/06/2025 | Date of earliest transaction, including exercise of stock options and disposition of shares. |
| 02/24/2026 | Date 13,500 stock options became exercisable. |
| 02/18/2027 | Expiration date for 3,734 stock options. |
| 03/08/2028 | Expiration date for 8,000 stock options. |
| 03/05/2029 | Expiration date for 12,000 stock options. |
| 02/24/2030 | Expiration date for 13,500 stock options. |
Recommendation
holdKeywords
National Healthcare Corp, NHC, Form 4, Insider Transaction, Stock Options, Executive Compensation, Beneficial Ownership, Josh McCreary, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.